WILMINGTON, N.C., Dec. 5 /PRNewswire-FirstCall/ -- aaiPharma Inc.
(Nasdaq: AAII) announced today that Dr. Philip S. Tabbiner, President and
Chief Executive Officer of aaiPharma, will be presenting at the First Albany
Corporation Annual Growth Conference in New York on Wednesday, December 10,
2003 at 2:20 p.m. (ET).
The presentation will be broadcast live over the Internet, then archived
and available for 10 days following the event. The web cast will be accessible
through the Company's website at http://www.aaipharma.com .
About aaiPharma
aaiPharma Inc. is a leading, science-based specialty pharmaceutical
company with corporate headquarters in Wilmington, North Carolina. With more
than 24 years of drug development expertise and a proven sales and marketing
track record, the Company is focused on acquiring, improving and marketing
well-known, branded medicines in pain management, critical care and
gastroenterology. In addition to its branded product portfolio and robust
pipeline, aaiPharma continues to offer comprehensive drug development services
to the pharmaceutical, biotechnology, generic and device industries through
its services division, AAI Development Services. For more information, please
visit aaiPharma's website at http://www.aaipharma.com .
SOURCE aaiPharma Inc.
 back to top
Related links:
http://www.aaipharma.com
CONTACT:
James B. Sloan, Jr., Senior Vice President,
Corporate Finance of aaiPharma Inc., +1-910-254-7690
|
